1. Beneficial Effects of Honey Flavonoids in Nonalcoholic Fatty Liver Disease: An Update
   Mohamad Taleuzzaman et al, 2020, Therapeutic Applications of Honey and its Phytochemicals CrossRef
2. Protective Effect of Fuzi Lizhong Decoction against Non-alcoholic Fatty Liver Disease via Anti-inflammatory Response through Regulating p53 and PPARG Signaling
   Jiayao Yang et al, 2020, Biological and Pharmaceutical Bulletin CrossRef
3. Catalpol prevents alteration of cholesterol homeostasis in non-alcoholic fatty liver disease via attenuating endoplasmic reticulum stress and NOX4 over-expression
   Jiting Yan et al, 2017, RSC Advances CrossRef
4. Interaction between iron and omega-3 fatty acids metabolisms: where is the cross-link?
   Magdalena Ogłuszka et al, 2022, Critical Reviews in Food Science and Nutrition CrossRef
5. Endogenous hepcidin synthesis protects the distal nephron against hemin and hemoglobin mediated necroptosis
   Rachel P. L. van Swelm et al, 2018, Cell Death & Disease CrossRef
6. Ischemic Preconditioning-Induced SOCS-1 Protects Rat Intestinal Ischemia Reperfusion Injury via Degradation of TRAF6
   Sheng-zhi Liu et al, 2017, Digestive Diseases and Sciences CrossRef
7. Antioxidative, inflammatory and immune responses in hydrogen peroxide-induced liver injury of tilapia (GIFT, Oreochromis niloticus)
   Rui Jia et al, 2019, Fish & Shellfish Immunology CrossRef
8. NF‐κB‐upregulated miR‐155‐5p promotes hepatocyte mitochondrial dysfunction to accelerate the development of nonalcoholic fatty liver disease through downregulation of STC1
   Miao Shen et al, 2022, Journal of Biochemical and Molecular Toxicology CrossRef
9. Nutrition and Liver Disease
   Claudia Mandato et al, 2017, Nutrients CrossRef
10. Evaluation of the Mechanism of Modified Lingguizhugan Decoction in the Treatment of Nonalcoholic Fatty Liver Disease
    Fuyuan Yang et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
11. Pilose antler peptide attenuates high-fat-diet-induced liver injury
    Lixin Xu et al, 2018, Toxicology Mechanisms and Methods CrossRef
12. Inhibition of CCL19 benefits non‑alcoholic fatty liver disease by inhibiting TLR4/NF‑κB‑p65 signaling
    Jiajing Zhao et al, 2018, Molecular Medicine Reports CrossRef
13. miR-182-5p Attenuates High-Fat -Diet-Induced Nonalcoholic Steatohepatitis in Mice
    Qionghe Liang et al, 2019, Annals of Hepatology CrossRef